- 1Pathology Department, Centro de Diagnóstico Biomédico (CDB), Liver Oncology Unit, Hospital Clinic Barcelona, Barcelona, Spain
- 2Barcelona Clinic Liver Cancer (BCLC) Group, Instituto De Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain
- 3Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain
- 4Facultad de Medicina, Universitat de Barcelona, Barcelona, Spain
- 5Liver Oncology Unit, Liver Unit, ICMDM, Hospital Clinic Barcelona, Barcelona, Spain
- 6Hepatobiliopancreatic Surgery and Liver and Pancreatic Transplantation Unit, Department of Surgery, Liver Oncology Unit, Instituto Clínic de Enfermedades Digestivas y Metabólicas (ICMDM), Hospital Clinic Barcelona, Barcelona, Spain
- 7Department of Molecular and Cellular Biomedicine, Instituto de Investigaciones Biomédicas de Barcelona, Consejo Superior de Investigaciones Científicas (IIBB-CSIC), Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalunya, Spain
- 8Medical Statistics Core Facility, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic Barcelona, Barcelona, Spain
A Correction on
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages
By Fuster-Anglada C, Corominas J, Marsal A, Llarch N, Iserte G, Sanduzzi-Zamparelli M, Forner A, Ferrer-Fábrega J, Holguin V, Morales A, Saavedra C, Reig M, Boix L, Marí M and Díaz A (2025) Front. Immunol. 16:1611365. doi: 10.3389/fimmu.2025.1611365
Affiliation “4. Facultad de Medicina, Universitat de Barcelona, Barcelona, Spain” was omitted for author “Carla Fuster-Anglada”. This affiliation has now been added for author “Carla Fuster-Anglada”.
The original version of this article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: hepatocellular carcinoma, lymphocytes, NK cells, immune exhaustion, sorafenib
Citation: Fuster-Anglada C, Corominas J, Marsal A, Llarch N, Iserte G, Sanduzzi-Zamparelli M, Forner A, Ferrer-Fábrega J, Holguin V, Morales A, Saavedra C, Reig M, Boix L, Marí M and Díaz A (2026) Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages. Front. Immunol. 17:1799354. doi: 10.3389/fimmu.2026.1799354
Received: 29 January 2026; Accepted: 30 January 2026;
Published: 05 February 2026.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2026 Fuster-Anglada, Corominas, Marsal, Llarch, Iserte, Sanduzzi-Zamparelli, Forner, Ferrer-Fábrega, Holguin, Morales, Saavedra, Reig, Boix, Marí and Díaz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Loreto Boix, bGJvaXhAcmVjZXJjYS5jbGluaWMuY2F0; Montserrat Marí, bW9ubWFyaUBjbGluaWMuY2F0
†These authors share first authorship
Carla Fuster-Anglada1,2,3,4†